Sasol (SOL) AGM 2024 summary
Event summary combining transcript, slides, and related documents.
AGM 2024 summary
14 Jan, 2026Opening remarks and agenda
Welcomed new board members and CFO, emphasizing board diversity and competencies.
Safety moment highlighted recent fatalities and reinforced commitment to Zero Harm.
Outlined meeting procedures, voting process, and Q&A protocols for shareholders.
Financial performance review
FY2024 turnover was ZAR 275 billion, down 5% from prior year, with improved gross margin (44%-46%).
Adjusted EBITDA was ZAR 60 billion, 9% lower than FY2023; Southern Africa remained the largest contributor.
Loss before interest and tax of ZAR 27 billion, mainly due to a ZAR 46 billion impairment in Chemicals America.
Free cash flow decreased by 60% year-on-year, but improved in the second half.
Capital spend was ZAR 30 billion, 2% lower than prior year, with focus on efficiency.
Board and executive committee updates
New appointments: Tim Cumming and David Eyton as Non-executive Directors, Walt Bruns as CFO and Executive Director.
Board succession planning continues to strengthen expertise, especially in energy transition.
Latest events from Sasol
- Positive free cash flow and cost control offset weak markets, but earnings fell on impairments.SOL
H1 202623 Feb 2026 - Higher fuel sales and production offset weak chemicals markets; FY26 fuel sales guidance raised.SOL
H1 2026 TU5 Feb 2026 - Targets up to R71bn EBITDA and net debt below US$3bn by FY28, driven by transformation and renewables.SOL
CMD 20253 Feb 2026 - Profitability fell on major impairments; FY25 focus is on margin, cash, and sustainability.SOL
H2 202423 Jan 2026 - EBITDA down 15%, revenue down 10%, free cash flow negative, no interim dividend declared.SOL
H1 202510 Dec 2025 - Free cash flow surged 75% and net debt hit a multi-year low, despite lower EBITDA.SOL
H2 202523 Nov 2025 - Higher Fuels and Mining output offset by weaker Chemicals Africa revenue amid market softness.SOL
Q1 202623 Oct 2025